Skip to contentLirea is launching soon. Join the waitlist to be notified.

Peptide tracker

Research peptide

ARA-290 tracker

A private tracker for your ARA-290: a clean daily course.

ARA-290 (cibinetide) is a peptide studied for nerve repair and inflammation, with small clinical studies behind it. It's typically run as a daily course. Lirea keeps a private record of your doses and course, on your phone, and no server in between.

One email on launch day, and nothing else. The app itself never asks for one.

Today

On your schedule

This week

ARA-290

on schedule

Logged

Weight check-in

trend
Log a dose

What you'll track

Made for how you actually take ARA-290.

A reconstituted subcutaneous injection, usually once daily in a set course.

A clean, defined course

ARA-290 is often run daily for a set number of weeks. Lirea reminds you each day and shows how far into the course you are.

How you're feeling, in context

Note nerve symptoms or discomfort against your doses, and let the trend show, privately.

Vial and reconstitution awareness

Note your concentration and doses remaining; Lirea keeps the math and storage straight.

A quiet, private record

Encrypted on your phone, with no account and no server.

Pen & vial inventory

A course runs over a few weeks. Lirea tracks doses remaining, reconstitution date, and storage.

Why Lirea

Your ARA-290 data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log, and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Check it yourself

    Turn on airplane mode. Everything but the paywall still works, because there is nothing on the other end.

Questions

ARA-290, tracked privately

What is ARA-290 studied for?

Small studies have looked at it for nerve repair and neuropathy symptoms. It's still investigational, so Lirea tracks your course without making claims.

Is ARA-290 FDA-approved?

No. It has an orphan-drug designation but is not an approved medication and is sold for research use only. Lirea is a private tracker, not medical advice.

Can Lirea handle a fixed daily course?

Yes. You set the course length, and Lirea reminds you each day and shows your progress.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Many peptides are not approved by the FDA and are sold for research use only; Lirea neither sells nor supplies any compound. Always follow the guidance of a qualified healthcare provider.

Launching soon

Keep it, and keep it yours.

Track your weekly dose, your titration, and how you’re feeling, all on your device. No account required. Be first to know when Lirea is live.

One email at launch. No spam, unsubscribe anytime. This list is separate from the app, and we never receive your health data. Privacy.

App Store, soonGoogle Play, soon